Technology to Reduce Infections

Steriwave™ Nasal Decolonization (ND), also known as MRSAid, is a broad-spectrum antimicrobial providing targeted decolonization safely, effectively, quickly.

  • Broad-spectrum: Kills all pathogens (bacterial, viral, fungal).

  • Non-resistance forming.

  • Safe and painless treatment for patients within 5 minutes.

  • High compliance, clinician administered.

  • Suitable for repetitive use (e.g. healthcare workers, frequent hospital visitors, long-term care facilities, outpatients, dialysis patients).

Photodisinfection eliminates topical pathogens rapidly and does not generate resistance.  It is a highly effective antimicrobial that targets bacterial biofilm, virus, yeasts and fungi without harming human tissue.

TECHNOLOGY

Not available for sale in the US.

Changing The Way We Look At Healthcare

Reduce the Germs, Reduce the Risk of Infection

The nose is one of the few body openings where bacteria, viruses and fungi have direct access to get inside the body. The nasal passages are important for filtering the air that we breathe in and stopping tiny foreign particles or microorganisms from entering the body. What many people do not know is that the nose and nasal passages are, or can be, the perfect environment for some bacteria, good and bad. For example, Staphylococcus aureus, commonly referred to as Staph, is a bacterium that lives in the nose of approximately one-third of the general population. These nasal germs are easily spread as we breathe, sneeze, or touch our face with our hands and then inadvertently transfer the germs to objects in the environment, our friends and co-workers, as well as other parts of our body. If you have a wound, surgical site, or other break in the skin, these germs can invade and cause an infection.

The process of removing or reducing germs in the nose is called, “nasal decolonization”. Nasal decolonization has been shown to reduce the risk of infection especially among high risk patients including those undergoing surgical procedures, immunocompromised, ICU patients and those requiring long-term and frequent healthcare services (e.g.; nursing homes, dialysis). Cleaning the nose of germs is part of good infection control practices such as frequent handwashing, skin preps before surgery, good oral care and a clean environment around us.

Kill Germs Living in the Nose in Minutes

A photosensitive agent activated by a specific wavelength of nonthermal light, causes rapid microbial kill through physical disruption of the microbial cell membrane.

Steriwave ND works by rapidly destroying microbes upon light activation.  The pathogens are unable to adapt to this treatment, eliminating the concern of antimicrobial resistance.

Real World Results

Canadian hospitals implemented our photodisinfection technology for orthopedic, spinal, and several other surgical
specialties with compelling results in the first year*.

  • 42% surgical site infection reduction.

  • CAD $1.9M costs avoided + 552 bed-days saved.

  • 3,068 surgical patients decolonized during initial year.

  • 94% compliance with decolonization.

  • 3.7x reduction in surgical site infection (SSI) risk (P=0.00026).

Since 2011, Steriwave ND has become a key component of the hospital’s surgical infection control efforts that, together with NSQIP and additional surgical bundles added in the intervening years, have led to the hospital reducing its overall SSI rate to 0.6%.


* Bryce E, Wong T, Forrester L, et al. Nasal photodisinfection and chlorhexidine wipes decrease surgical site infections: a historical control study and propensity analysis. J Hosp Infect. 2014 Oct;88(2):89-95.

Steriwave ND’s user-friendly technology is well-received by nurses and patients alike with over
8,000 surgical patients decolonized annually.

Resources

Research

Steriwave ND is not available for sale in the US.

Upcoming Events

Quick Links

Technology
Solutions
News

Light Years Ahead

Committed to providing simple solutions to complex infections.

Contact Us
Share this post via Email
Share this post on Twitter
Share this post on LinkedIn
Print PDF of this post